SEC Form 4 · accession 0001140361-16-069127
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher T Cox
Officer — EVP & Chief Corp. Dev. Officer
Period of report
Jun 7, 2016
Accepted (ET)
Jun 8, 2016 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 7, 2016 | P | 20,800 | $37.05 | A | 20,800 | D | |
| Common StockF2 | Jun 7, 2016 | P | 6,200 | $37.49 | A | 27,000 | D | |
| Common StockF3,F4 | Jun 7, 2016 | P | 26,340 | $37.96 | A | 26,340 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average purchase price of the shares purchased ranging from a low of $36.46 to a high of $37.35 per share. The reporting person undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price for this footnote (1) and footnotes (2) and (3).
- F2Represents the weighted average purchase price of the shares purchased ranging from a low of $37.41 to a high of $37.74 per share.
- F3Represents the weighted average purchase price of the shares purchased ranging from a low of $37.85 to a high of $38.02 per share.
- F4The reporting person holds a power of attorney with respect to this account. Members of the reporting person's immediate family may be considered to have a pecuniary interest in this account. The reporting person disclaims beneficial ownership of the shares held by this account except to the extent of his pecuniary interest therein.